Development of a prognostically relevant 'angiogenic signature' in ascites from patients with advanced ovarian cancer

被引：0
|
作者：
Gavalas, N. G. [1 ]
Trachana, S. -P. [1 ]
Pilalis, E. [2 ]
Chatziioannou, A. [2 ]
Papadodima, O. [2 ]
Terpos, E. [1 ]
Dimopoulos, M. A. [1 ]
Bamias, A. [1 ]
机构：
[1] Univ Athens, Sch Med, GR-11527 Athens, Greece
[2] Natl Hellen Res Fdn, Athens, Greece
来源：
IMMUNOLOGY | 2014年 / 143卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
479
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [31] Prognostically relevant Factors after Radiotherapy and Chemotherapy in Patients with small cell Lung Cancer
    Kassik, Marie-Theres
    Vordermark, Dirk
    Kornhuber, Christine
    Medenwald, Daniel
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S97 - S98
  • [32] ASCITES LEVELS OF HAPTOGLOBIN IN PATIENTS WITH OVARIAN-CANCER
    ELG, SA
    CARSON, LF
    FOWLER, JM
    TWIGGS, LB
    MORADI, MM
    RAMAKRISHNAN, S
    CANCER, 1993, 71 (12) : 3938 - 3941
  • [33] Doxorubicin levels in the serum and ascites of patients with ovarian cancer
    Gotlieb, W. H.
    Bruchim, I.
    Ben-Baruch, G.
    Davidson, B.
    Zeltser, A.
    Andersen, A.
    Olsen, H.
    EJSO, 2007, 33 (02): : 213 - 215
  • [34] Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer
    Werner, Bonnita
    Powell, Elyse
    Duggan, Jennifer
    Cortesi, Marilisa
    Lee, Yeh Chen
    Arora, Vivek
    Athavale, Ramanand
    Dean, Michael
    Warton, Kristina
    Ford, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] PREDICTION OF CHEMOTHERAPY SENSITIVITY ON ASCITES OF OVARIAN CANCER PATIENTS
    den Ouden, J. E.
    Zaman, G. J. R.
    Dylus, J.
    Buijsman, R. C.
    Massuger, L. F. A. G.
    van Altena, A. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 150 - 150
  • [36] Analysis of Aniogenesis Markers in Ovarian Cancer identifies PDGFA (Platelet Derived Growth Factor A) as a prognostically relevant Molecule
    Wieser, Autoren, V
    Strimmer, A.
    Fiegl, H.
    Zeimet, A. G.
    Marth, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (04) : E5 - E6
  • [37] Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites
    Liu, E. L.
    Mi, R. R.
    Wang, D. H.
    Wang, L. Q.
    Zhang, Y. M.
    Chen, W. M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (02) : 209 - 213
  • [38] Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer
    Saltzman, AK
    Hartenbach, EM
    Carter, JR
    Contreras, DN
    Twiggs, LB
    Carson, LF
    Ramakrishnan, S
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 47 (03) : 200 - 204
  • [39] Overview of anti-angiogenic agents in development for ovarian cancer
    Burger, Robert A.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : 230 - 238
  • [40] Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites
    Jakimovska, Marina
    Cerne, Katarina
    Verdenik, Ivan
    Kobal, Borut
    RADIOLOGY AND ONCOLOGY, 2014, 48 (03) : 307 - 313
12345